Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma

Journal of Korean Medical Science

Volumn 14, Issue 4, 1999, Pages 417-423

  Joo, Young Eun ^a   Seo, Kang Seok ^a   Kim, Jin ^b   Kim, Hyun Soo ^a   Rew, Jong Sun ^a   Park, Chang Soo ^a   Kim, Sei Jong ^a  

^a Chonnam National University Medical School   (South Korea)

^b Seonam University   (South Korea)

Author keywords

Colorectal neoplasms; Immunohistochemistry; In situ hybridization; Tissue inhibitors of metalloproteinases

Indexed keywords

ANTIBODY; COLLAGENASE; GELATINASE; GELATINASE A; GELATINASE B; MESSENGER RNA; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; COLORECTAL TUMOR; DNA PROBE; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; STROMA CELL; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; COLLAGENASES; COLORECTAL NEOPLASMS; DNA PROBES; FEMALE; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; STROMAL CELLS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0033173324     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.4.417     Document Type: Article

References (28)

1. Matrisan LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 1990; 6: 121-5.
2. Murphy G, Reynolds JJ, Hembry RM. Metalloproteinases and cancer invasion and metastasis. Int J Cancer 1989; 44: 757-60.
3. Stearns MA, Wang M. Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 1993; 53: 878-83.
4. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill FR. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993; 53: 5365-9.
5. D'Errico A, Garbisa S, Liotta LA, Castranovo V, Stetler-Stevenson WG, Grigioni WF. Augmentation of collagenase IV, lamin receptor and Ki 62 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 1991; 4: 239-46.
6. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafdie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
7. Liotta LA, Steeg PA, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
8. Sellers A, Murphy G, Meickle MC, Reynolds JJ. Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases. Biochem Biphys Res Commun 1979; 87: 581-7.
9. Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase (TIMP 2). J Biol Chem 1989; 264: 17374-8.
10. Uria JA, Ferrando AA, Velasco G, Freije JMP, Lopez-Otin C. Structure and expression in breast tumors of human TIMP 3, a new member of metalloproteinase inhibitor family. Cancer Res 1994; 54: 2091-4.
11. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Chi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271: 30375-80.
12. Welgus HG, Stricklin GP. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 1983; 258: 12259-64.
13. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 13933-8.
14. Zeng ZS, Cohen AM, Zahng ZF, Stetler-Stevenson W, Guillem JG. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastasis. Clin Cancer Res 1995; 1: 899-906.
15. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR. Comparative analysis of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996; 73: 1401-8.
16. Visscher DW, Hoyhtya M, Ottosen SK, Liang C-M, Sarkar FH, Crissman JD, Fridman R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 1994; 59: 339-44.
17. Mimori K, Mori M, Shiraishi T, Fujie T, Baba K, Haraguchi M, Abe R, Ueo H, Akiyoshi T. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 1997; 76: 531-6.
18. Wood M, Fudge K, Mohler JL, Frost AR, Garcia F, Wang M, Steams ME. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis 1997; 15: 246-58.
19. Park CS, Manahan LJ, Brigati DJ. Automated molecular pathology: one hour in situ hybridization. J Histotechnol 1995; 2: 462-7.
20. Reed JA, Manahan LJ, Park CS, Brigati DJ. Complete one-hour immunohistochemistry based on capillary action Biotechniques 1992; 13: 434-43.
21. Alvarez OA, Carmichael DF, DeClerk YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990; 82: 589-95.
22. Ponton A, Coulombe B, Skup D. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 1991; 51: 2138-43.
23. Clark IM, Powell LK, Cawston TE. Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from skin fibroblasts. Biochem Biophys Res Commun 1994; 203: 874-80.
24. Louis C, David WG, Noelle B, Mark DJ. Metalloproteinase inhibition and erythroid potentiation are in dependent activities of tissue inhibitor of metalloproteinases-1. Blood 1995; 86: 4506-15.
25. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochem Biophys Acta 1990; 1052: 366-78.
26. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB. Localization of transforming growth factor-β isotypes in lesions of the human breast. Hunt Pathol 1992; 23: 13-20.
27. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafdie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
28. Ring P, Johansson K, Hoyhtya M, Rubin K, Lindmark G. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumor stage. Br J Cancer 1997; 76: 805-11.